ATRC Stock - AtriCure Inc.

ATRC Stock Chart

ATRC Profile

AtriCure, Inc. specializes in the development, manufacturing, and distribution of innovative medical devices designed for surgical cardiac ablation and nerve intercostal procedures. Operating globally, the company serves medical centers across the United States, Europe, Asia, and other international markets. AtriCure's product portfolio includes advanced technologies such as the Isolator Synergy Clamps, which are disposable radio frequency products used for precise cardiac tissue ablation.

The company also offers multifunctional pens and linear ablation devices like the MAX Pen, enabling surgeons to diagnose cardiac arrhythmias, perform temporary cardiac pacing, and conduct tissue ablation with a single device. Additionally, AtriCure provides the Coolrail device for creating extended linear lines of ablation, enhancing surgical efficiency and accuracy.

Among its notable products, AtriCure features the cryoICE Cryoablation System for creating linear ablations of varying lengths and the EPi-Sense Guided Coagulation System for treating atrial fibrillation. The company's offerings further include the AtriClip System for implantable devices and the LARIAT System, a suture-based solution for soft-tissue closure across diverse anatomical shapes. Headquartered in Mason, Ohio, AtriCure was founded in 2000 and continues to expand its market presence through a combination of direct sales personnel and independent distributors, ensuring its advanced surgical solutions reach healthcare providers worldwide.

ATRC Revenue Chart

ATRC Earnings

Analyst Ratings